tiprankstipranks
PaySign (PAYS)
NASDAQ:PAYS
US Market

PaySign (PAYS) Earnings Dates, Call Summary & Reports

Compare
844 Followers

Earnings Data

Report Date
May 13, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.02
Last Year’s EPS
0.01
Same Quarter Last Year
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 25, 2025
|
% Change Since: -21.77%
|
Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call indicated strong growth in the patient affordability business and strategic expansion through acquisitions, which were partly offset by challenges in the plasma business and increased operating expenses. The overall sentiment is balanced with significant achievements in revenue growth and strategic initiatives, but also notable challenges in specific segments.
Company Guidance
In the Paysign, Inc. earnings call for the fourth quarter and full year 2024, significant guidance was provided, emphasizing several key financial metrics and projections. The company reported an impressive 23.5% increase in full-year revenue, reaching $58.4 million, alongside a 43.3% rise in adjusted EBITDA to $9.6 million, with adjusted EBITDA margins improving by 230 basis points to 16.5%. The patient affordability segment emerged as a primary growth driver, boasting a 212% increase in annual revenue to $12.7 million, a 272% rise in claims processed, and a 77% growth in net programs added. For 2025, Paysign anticipates a continuation of this momentum, projecting a doubling of revenue in the patient affordability business. However, the plasma donor compensation business experienced a modest 4.6% revenue increase, with challenges expected to persist due to oversupply issues. Paysign plans to add 10 to 15 new plasma centers in 2025. The company's initial guidance for 2025 projects total revenues between $68.5 million and $70 million, with plasma revenue comprising approximately 57.5% of the total. Gross profit margins are anticipated to be between 62% and 64%, and adjusted EBITDA is forecasted to range from $12.5 million to $13.5 million. The strategic acquisition of Gamma Innovation LLC is also expected to enhance Paysign's capabilities and expand its total addressable market, although its revenue contributions are not yet fully incorporated into the 2025 guidance.
Strong Revenue Growth
For the full year 2024, revenue increased by 23.5% to $58.4 million, and adjusted EBITDA increased 43.3% to $9.6 million. Adjusted EBITDA margins improved by 230 basis points to 16.5%.
Patient Affordability Business Success
The patient affordability segment grew 212% year-over-year, reaching $12.7 million in revenue compared to $4.1 million in 2023. Claims processed increased by 272%, and 33 net programs were added, representing a 77% increase over the previous year.
Strategic Acquisition
Paysign announced the acquisition of Gamma Innovation LLC, enhancing their capability to offer integrated solutions for plasma donor and pharmaceutical patient engagement, and marking their entry into the high-margin software-as-a-service market.
Strong Financial Position
Paysign exited the year with $10.8 million in unrestricted cash and zero debt.
---

PaySign (PAYS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PAYS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 20252025 (Q1)
0.02 / -
0.01
Mar 25, 20252024 (Q4)
0.02 / 0.02
0.1-80.00% (-0.08)
Nov 05, 20242024 (Q3)
0.01 / 0.03
0.0250.00% (<+0.01)
Jul 31, 20242024 (Q2)
0.01 / 0.01
0
May 07, 20242024 (Q1)
0.00 / 0.01
0
Mar 26, 20242023 (Q4)
0.02 / 0.10
0.01900.00% (+0.09)
Nov 07, 20232023 (Q3)
0.01 / 0.02
0.020.00% (0.00)
Aug 08, 20232023 (Q2)
0.00 / 0.00
0
May 10, 20232023 (Q1)
>-0.01 / 0.00
-0.01
Mar 21, 20232022 (Q4)
0.01 / 0.01
0
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

PAYS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 25, 2025$2.48$2.27-8.47%
Nov 05, 2024$3.83$4.06+6.01%
Jul 31, 2024$5.33$4.87-8.63%
May 07, 2024$4.67$4.57-2.14%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does PaySign (PAYS) report earnings?
PaySign (PAYS) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
    What is PaySign (PAYS) earnings time?
    PaySign (PAYS) earnings time is at May 13, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PAYS EPS forecast?
          PAYS EPS forecast for the fiscal quarter 2025 (Q1) is 0.02.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis